TherapeuticsMD (TXMD) Leases (2019 - 2025)
TherapeuticsMD (TXMD) has disclosed Leases for 7 consecutive years, with $5.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Leases fell 12.49% year-over-year to $5.5 million, compared with a TTM value of $5.5 million through Sep 2025, down 12.49%, and an annual FY2024 reading of $6.1 million, down 11.22% over the prior year.
- Leases was $5.5 million for Q3 2025 at TherapeuticsMD, down from $5.7 million in the prior quarter.
- Across five years, Leases topped out at $9.2 million in Q1 2021 and bottomed at $5.5 million in Q3 2025.
- Average Leases over 5 years is $7.2 million, with a median of $7.2 million recorded in 2023.
- Peak annual rise in Leases hit 5.66% in 2021, while the deepest fall reached 15.89% in 2021.
- Year by year, Leases stood at $8.2 million in 2021, then decreased by 7.94% to $7.6 million in 2022, then decreased by 9.33% to $6.9 million in 2023, then dropped by 11.22% to $6.1 million in 2024, then fell by 9.62% to $5.5 million in 2025.
- Business Quant data shows Leases for TXMD at $5.5 million in Q3 2025, $5.7 million in Q2 2025, and $5.9 million in Q1 2025.